Vitrectomy for macular edema due to retinal vein occlusion

Kazuyuki Kumagai,1 Nobuchika Ogino,2 Marie Fukami,1 Mariko Furukawa11Kami-iida Daiichi General Hospital, Aichi, Japan; 2Shinjo Ophthalmologic Institute, Miyazaki, JapanPurpose: To determine the long-term outcomes of vitrectomy for the macular edema associated with a retinal vein occlusion (RVO).Meth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kumagai K, Ogino N, Fukami M, Furukawa M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/2bc341b2e8904b769aa7e24e0b775b27
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2bc341b2e8904b769aa7e24e0b775b27
record_format dspace
spelling oai:doaj.org-article:2bc341b2e8904b769aa7e24e0b775b272021-12-02T06:35:55ZVitrectomy for macular edema due to retinal vein occlusion1177-5483https://doaj.org/article/2bc341b2e8904b769aa7e24e0b775b272019-06-01T00:00:00Zhttps://www.dovepress.com/vitrectomy-for-macular-edema-due-to-retinal-vein-occlusion-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Kazuyuki Kumagai,1 Nobuchika Ogino,2 Marie Fukami,1 Mariko Furukawa11Kami-iida Daiichi General Hospital, Aichi, Japan; 2Shinjo Ophthalmologic Institute, Miyazaki, JapanPurpose: To determine the long-term outcomes of vitrectomy for the macular edema associated with a retinal vein occlusion (RVO).Methods: This was a retrospective, consecutive, interventional case series. The intraoperative procedures included internal limiting membrane peeling, arteriovenous sheathotomy, radial optic neurotomy, and intravitreal triamcinolone acetonide injection at the end of the surgery. The main outcome was the best-corrected visual acuity (BCVA).Results: Eight hundred and fifty-four eyes of 854 patients were studied. The eyes consisted of 602 with branch RVO (BRVO), 74 with hemi-central RVO (hemi-CRVO), 87 with nonischemic central retinal vein occlusion (CRVO), and 91 with ischemic CRVO. The mean follow-up period was 68.6 months with a range of 12 to 262 months. The mean BCVA was significantly improved at the final visit (P<0.0001 to 0.0016). The final BCVA improved in 74.4% of the BRVO eyes, in 58.1% of the hemi-CRVO eyes, in 57.4% of the nonischemic CRVO eyes, and in 51.6% of the ischemic CRVO eyes. Multiple regression analysis showed there was no significant relationship between the intraoperative combined procedures and the final BCVA.Conclusions: The results indicate that the type of RVO is significantly associated with the final BCVA, and vitrectomy is a treatment option to improve and maintain BCVA for a long term.Keywords: retinal vein occlusion, vitrectomy, macular edema, internal limiting membraneKumagai KOgino NFukami MFurukawa MDove Medical Pressarticleretinal vein occlusionvitrectomymacular edemainternal limiting membraneOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 13, Pp 969-984 (2019)
institution DOAJ
collection DOAJ
language EN
topic retinal vein occlusion
vitrectomy
macular edema
internal limiting membrane
Ophthalmology
RE1-994
spellingShingle retinal vein occlusion
vitrectomy
macular edema
internal limiting membrane
Ophthalmology
RE1-994
Kumagai K
Ogino N
Fukami M
Furukawa M
Vitrectomy for macular edema due to retinal vein occlusion
description Kazuyuki Kumagai,1 Nobuchika Ogino,2 Marie Fukami,1 Mariko Furukawa11Kami-iida Daiichi General Hospital, Aichi, Japan; 2Shinjo Ophthalmologic Institute, Miyazaki, JapanPurpose: To determine the long-term outcomes of vitrectomy for the macular edema associated with a retinal vein occlusion (RVO).Methods: This was a retrospective, consecutive, interventional case series. The intraoperative procedures included internal limiting membrane peeling, arteriovenous sheathotomy, radial optic neurotomy, and intravitreal triamcinolone acetonide injection at the end of the surgery. The main outcome was the best-corrected visual acuity (BCVA).Results: Eight hundred and fifty-four eyes of 854 patients were studied. The eyes consisted of 602 with branch RVO (BRVO), 74 with hemi-central RVO (hemi-CRVO), 87 with nonischemic central retinal vein occlusion (CRVO), and 91 with ischemic CRVO. The mean follow-up period was 68.6 months with a range of 12 to 262 months. The mean BCVA was significantly improved at the final visit (P<0.0001 to 0.0016). The final BCVA improved in 74.4% of the BRVO eyes, in 58.1% of the hemi-CRVO eyes, in 57.4% of the nonischemic CRVO eyes, and in 51.6% of the ischemic CRVO eyes. Multiple regression analysis showed there was no significant relationship between the intraoperative combined procedures and the final BCVA.Conclusions: The results indicate that the type of RVO is significantly associated with the final BCVA, and vitrectomy is a treatment option to improve and maintain BCVA for a long term.Keywords: retinal vein occlusion, vitrectomy, macular edema, internal limiting membrane
format article
author Kumagai K
Ogino N
Fukami M
Furukawa M
author_facet Kumagai K
Ogino N
Fukami M
Furukawa M
author_sort Kumagai K
title Vitrectomy for macular edema due to retinal vein occlusion
title_short Vitrectomy for macular edema due to retinal vein occlusion
title_full Vitrectomy for macular edema due to retinal vein occlusion
title_fullStr Vitrectomy for macular edema due to retinal vein occlusion
title_full_unstemmed Vitrectomy for macular edema due to retinal vein occlusion
title_sort vitrectomy for macular edema due to retinal vein occlusion
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/2bc341b2e8904b769aa7e24e0b775b27
work_keys_str_mv AT kumagaik vitrectomyformacularedemaduetoretinalveinocclusion
AT oginon vitrectomyformacularedemaduetoretinalveinocclusion
AT fukamim vitrectomyformacularedemaduetoretinalveinocclusion
AT furukawam vitrectomyformacularedemaduetoretinalveinocclusion
_version_ 1718399802915422208